Home>Topics>Companies>IMS Health

IMS Health RX

  1. All
  2. Commentary
  3. Headlines
    1. Belviq Sales Benefit From Advertising - Up 2.8%

      Headlines

      Fri, 26 Sep 2014

      Pharmaceuticals (NASDAQ: ARNA ) saw a nice week over week gain on the heels of a more robust advertising campaign. According to IMS Health , script sales this week were about 11,900 which represents a gain of 2.8% over last weeks numbers. While a 2

    2. IG Labs acquires drug portfolio from AstraZeneca

      Headlines

      Thu, 25 Sep 2014

      been cleared by the FDA via ANDAs or NDAs prior to their discontinuation or withdrawal from the market. According to IMS Health , the U.S. addressable market for the products is ~$200M. Almost half of the 18 drugs are on the FDA shortage list

    3. IMS Has Deleveraged While Growing Revenues And Executing Accretive Acquisitions

      Headlines

      Thu, 25 Sep 2014

      By Dallas Salazar : Five months ago when IMS Health Holdings, Inc. (NYSE: IMS ) held its IPO I opined that the company should be purchased in Core Position quantity. Now, for

    4. Dr. Reddy's launches generic Xopenex in U.S.

      Headlines

      Wed, 24 Sep 2014

      generic version of Sunovion Pharmaceuticals' Xopenex (levalbuterol hydrochloride) inhalation solution. According to IMS Health , the U.S. market is ~$270M. Post your comment!

    5. Lannett begins shipping oxycodone solution

      Headlines

      Mon, 22 Sep 2014

      Lannett Company (NYSE: LCI ) commences shipping its recently-approved oxycodone hydrochloride oral solution USP, 100 mg/5 mL. The U.S. wholesale market is ~43M per IMS Health . The company reaffirms its fiscal 2015 guidance. Post your comment!

    6. Belviq Sales See Holiday Dip - Still On Track

      Headlines

      Fri, 12 Sep 2014

      this week due to the Labor Day holiday. Sales were down 12% from last week's numbers according to industry source IMS Health . While seeing sales dip is never a positive, the news was essentially expected and the stock price did not carry an

    7. Strong Portfolio Will Drive Growth For Mylan

      Headlines

      Thu, 11 Sep 2014

      antiretroviral therapies upon which around 40% of HIV/AIDS patients in developing countries depend. According to IMS Health , Mylan currently has 294 abbreviated new drug applications pending for FDA approval which represent $105.7 billion

    8. FDA clears Lannett's generic oxycodone solution

      Headlines

      Wed, 10 Sep 2014

      equivalent of Lehigh Valley Technologies' Oxycodone Hydrochloride Oral Solution USP, 100 mg/5 mL. According the IMS Health , the U.S. wholesale market is ~$43M per year. Post your comment!

    9. Mylan secures U.S. rights to DVT drug

      Headlines

      Wed, 10 Sep 2014

      escrow pending the satisfaction of certain conditions. Aspen will supply Arixtra and its generic to Mylan. According to IMS Health , U.S. sales of branded Arixtra were $18.8M for the 12-month period ending June 30, 2014. Generic Arixtra sales

    10. Belviq Sales See Modest Rise This Week - Caution For Next Week Because Of Holiday

      Headlines

      Fri, 5 Sep 2014

      pill Belviq from Arena Pharmaceuticals (NASDAQ: ARNA ) were up modestly this past week, according to industry tracker IMS Health . Total sales were a bit over 11,400 scripts, and the percentage gain from last week was about 1.4%. New scripts

    « Prev12345Next »
    Content Partners